These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 1707981)

  • 1. Homooligomerization of the hemagglutinin-neuraminidase glycoprotein of human parainfluenza virus type 3 occurs before the acquisition of correct intramolecular disulfide bonds and mature immunoreactivity.
    Collins PL; Mottet G
    J Virol; 1991 May; 65(5):2362-71. PubMed ID: 1707981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folding and oligomerization properties of a soluble and secreted form of the paramyxovirus hemagglutinin-neuraminidase glycoprotein.
    Parks GD; Lamb RA
    Virology; 1990 Oct; 178(2):498-508. PubMed ID: 2219705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular maturation and transport of the SV5 type II glycoprotein hemagglutinin-neuraminidase: specific and transient association with GRP78-BiP in the endoplasmic reticulum and extensive internalization from the cell surface.
    Ng DT; Randall RE; Lamb RA
    J Cell Biol; 1989 Dec; 109(6 Pt 2):3273-89. PubMed ID: 2557352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular processing and transport of NH2-terminally truncated forms of a hemagglutinin-neuraminidase type II glycoprotein.
    Spriggs MK; Collins PL
    J Cell Biol; 1990 Jul; 111(1):31-44. PubMed ID: 2164031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic and structural properties of the hemagglutinin-neuraminidase glycoprotein of human parainfluenza virus type 3: sequence analysis of variants selected with monoclonal antibodies which inhibit infectivity, hemagglutination, and neuraminidase activities.
    van Wyke Coelingh KL; Winter CC; Jorgensen ED; Murphy BR
    J Virol; 1987 May; 61(5):1473-7. PubMed ID: 2437318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody responses of humans and nonhuman primates to individual antigenic sites of the hemagglutinin-neuraminidase and fusion glycoproteins after primary infection or reinfection with parainfluenza type 3 virus.
    van Wyke Coelingh KL; Winter CC; Tierney EL; Hall SL; London WT; Kim HW; Chanock RM; Murphy BR
    J Virol; 1990 Aug; 64(8):3833-43. PubMed ID: 1695256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the individual cysteine residues in the formation of the mature, antigenic HN protein of Newcastle disease virus.
    McGinnes LW; Morrison TG
    Virology; 1994 May; 200(2):470-83. PubMed ID: 8178436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of cotranslational disulfide bond formation in the folding of the hemagglutinin-neuraminidase protein of Newcastle disease virus.
    McGinnes LW; Morrison TG
    Virology; 1996 Oct; 224(2):465-76. PubMed ID: 8874507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibiting Human Parainfluenza Virus Infection by Preactivating the Cell Entry Mechanism.
    Bottom-Tanzer SF; Rybkina K; Bell JN; Alabi CA; Mathieu C; Lu M; Biswas S; Vasquez M; Porotto M; Melero JA; Más V; Moscona A
    mBio; 2019 Feb; 10(1):. PubMed ID: 30782664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystallization of Sendai virus HN protein complexed with monoclonal antibody Fab fragments.
    Laver WG; Thompson SD; Murti KG; Portner A
    Virology; 1989 Jul; 171(1):291-3. PubMed ID: 2545033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replacement of the ectodomains of the hemagglutinin-neuraminidase and fusion glycoproteins of recombinant parainfluenza virus type 3 (PIV3) with their counterparts from PIV2 yields attenuated PIV2 vaccine candidates.
    Tao T; Skiadopoulos MH; Davoodi F; Riggs JM; Collins PL; Murphy BR
    J Virol; 2000 Jul; 74(14):6448-58. PubMed ID: 10864657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-linked glycan at residue 523 of human parainfluenza virus type 3 hemagglutinin-neuraminidase masks a second receptor-binding site.
    Mishin VP; Watanabe M; Taylor G; Devincenzo J; Bose M; Portner A; Alymova IV
    J Virol; 2010 Mar; 84(6):3094-100. PubMed ID: 20053750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective assembly and intracellular transport of mutant paramyxovirus hemagglutinin-neuraminidase proteins containing altered cytoplasmic domains.
    Parks GD; Lamb RA
    J Virol; 1990 Aug; 64(8):3605-16. PubMed ID: 2164588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the parainfluenza virus fusion and hemagglutinin-neuraminidase glycoproteins on cell surfaces.
    Yao Q; Hu X; Compans RW
    J Virol; 1997 Jan; 71(1):650-6. PubMed ID: 8985396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformationally sensitive antigenic determinants on the HN glycoprotein of Newcastle disease virus form with different kinetics.
    McGinnes LW; Morrison TG
    Virology; 1994 Mar; 199(2):255-64. PubMed ID: 7510081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hemagglutinin-neuraminidase glycoproteins of human parainfluenza virus type 1 and Sendai virus have high structure-function similarity with limited antigenic cross-reactivity.
    Gorman WL; Gill DS; Scroggs RA; Portner A
    Virology; 1990 Mar; 175(1):211-21. PubMed ID: 1689918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different roles of individual N-linked oligosaccharide chains in folding, assembly, and transport of the simian virus 5 hemagglutinin-neuraminidase.
    Ng DT; Hiebert SW; Lamb RA
    Mol Cell Biol; 1990 May; 10(5):1989-2001. PubMed ID: 2183015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological relationships between mumps virus and parainfluenza viruses studied with monoclonal antibodies.
    Orvell C; Rydbeck R; Löve A
    J Gen Virol; 1986 Sep; 67 ( Pt 9)():1929-39. PubMed ID: 3018131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-translational processing and oligomerization of the fusion glycoprotein of human respiratory syncytial virus.
    Collins PL; Mottet G
    J Gen Virol; 1991 Dec; 72 ( Pt 12)():3095-101. PubMed ID: 1765771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination with a human parainfluenza virus type 3 chimeric FHN glycoprotein formulated with a combination adjuvant induces protective immunity.
    Garg R; Brownlie R; Latimer L; Gerdts V; Potter A; van Drunen Littel-van den Hurk S
    Vaccine; 2017 Dec; 35(51):7139-7146. PubMed ID: 29153777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.